MedPath
NMPA Approval

Digoxin Injection

国药准字H20247171

July 19, 2024

国药准字H20233758

Drug Information

地高辛注射液

注射剂

1ml:0.1mg

化学药品

July 19, 2024

Company Information

Applicant Company

广州市黄埔区开源大道11号A3栋601室

Manufacturing Company

成都市海峡两岸科技产业开发园柳台大道222号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

地高辛注射液 - NMPA 批准文号 | MedPath